行为干预增加蔬菜摄入对早期前列腺癌进展的影响:MEAL随机临床试验
MEAL研究是在91家美国泌尿科和肿瘤内科门诊开展的随机临床试验,纳入478例50-80岁早期前列腺癌患者,随机分为电话咨询行为干预组(每日7份以上蔬菜)或对照组(书面饮食信息)。主要终点为进展时间,结果显示两组进展时间无显著差异,24个月无进展生存率干预组43.5% vs 对照组41.4%,差异2.1%(95%CI -8.1%至12.2%)。
要点
- 行为干预增加蔬菜摄入未显著降低早期前列腺癌进展风险。
- 24个月无进展生存率干预组43.5% vs 对照组41.4%,差异无统计学意义。
- 研究可能把握度不足,不能排除临床重要差异。
核心结论
- 在主动监测的早期前列腺癌男性中,增加蔬菜摄入的行为干预未显著降低前列腺癌进展风险。
研究设计与样本
- MEAL研究(CALGB 70807)为随机临床试验,在美国91家泌尿科和肿瘤内科门诊纳入478例50-80岁活检证实前列腺腺癌患者。
- 患者随机分为电话咨询行为干预组(每日7份以上蔬菜,n=237)或对照组(书面饮食信息,n=241)。
- 主要终点为进展时间,进展定义为PSA≥10 ng/mL、PSA倍增时间<3年或随访活检升级。
主要发现
- 478例随机患者中443例(93%)纳入主要分析,共245例进展事件(干预组124例,对照组121例)。
- 进展时间无显著差异:未调整HR 0.96(95%CI 0.75-1.24),调整HR 0.97(95%CI 0.76-1.25)。
- 24个月Kaplan-Meier无进展百分比干预组43.5%(95%CI 36.5%-50.6%),对照组41.4%(95%CI 34.3%-48.7%),差异2.1%(95%CI -8.1%至12.2%)。
临床怎么用
- 研究结果不支持使用该行为干预来降低早期前列腺癌患者的进展风险。
局限性
- 研究可能把握度不足,无法识别临床重要差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Guidelines endorsing vegetable-enriched diets to improve outcomes for prostate cancer survivors are based on expert opinion, preclinical studies, and observational data. OBJECTIVE: To determine the effect of a behavioral intervention that increased vegetable intake on cancer progression in men with early-stage prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: The Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]) was a randomized clinical trial conducted at 91 US urology and medical oncology clinics that enrolled 478 men aged 50 to 80 years with biopsy-proven prostate adenocarcinoma (International Society of Urological Pathology grade group = 1 in those <70 years and ≤2 in those ≥70 years), stage cT2a or less, and serum prostate-specific antigen (PSA) level less than 10 ng/mL. Enrollment occurred from January 2011 to August 2015; 24-month follow-up occurred from January 2013 to August 2017. INTERVENTIONS: Patients were randomized to a counseling behavioral intervention by telephone promoting consumption of 7 or more daily vegetable servings (MEAL intervention; n = 237) or a control group, which received written information about diet and prostate cancer (n = 241). MAIN OUTCOMES AND MEASURES: The primary outcome was time to progression; progression was defined as PSA level of 10 ng/mL or greater, PSA doubling time of less than 3 years, or upgrading (defined as increase in tumor volume or grade) on follow-up prostate biopsy. RESULTS: Among 478 patients randomized (mean [SD] age, 64 [7] years; mean [SD] PSA level, 4.9 [2.1] ng/mL), 443 eligible patients (93%) were included in the primary analysis. There were 245 progression events (intervention: 124; control: 121). There were no significant differences in time to progression (unadjusted hazards ratio, 0.96 [95% CI, 0.75 to 1.24]; adjusted hazard ratio, 0.97 [95% CI, 0.76 to 1.25]). The 24-month Kaplan-Meier progression-free percentages were 43.5% [95% CI, 36.5% to 50.6%] and 41.4% [95% CI, 34.3% to 48.7%] for the intervention and control groups, respectively (difference, 2.1% [95% CI, -8.1% to 12.2%]). CONCLUSIONS AND RELEVANCE: Among men with early-stage prostate cancer managed with active surveillance, a behavioral intervention that increased vegetable consumption did not significantly reduce the risk of prostate cancer progression. The findings do not support use of this intervention to decrease prostate cancer progression in this population, although the study may have been underpowered to identify a clinically important difference. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01238172.
引用
- Parsons JK, Zahrieh D, Mohler JL, et al. Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial. JAMA. 2020. PMID: 31935026. doi:10.1001/jama.2019.20207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。